Fulgent Genetics (FLGT)
Combines hereditary-cancer and pathology testing with a nanoencapsulated cancer-drug pipeline in clinical trials.
$21.80
vs last close+0.26 (+1.18%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 58.32% | 16.05M shares | |
|---|---|---|---|
| 147 holders · as of Jun 30, 2026 | |||
| Insiders | 9.74% | 2.68M shares | |
| 7 holders · as of Sep 3, 2026 | |||
| Strategic holders | 3.88% | 1.07M shares | |
| 1 holder · as of Jun 12, 2020 | |||
| Other | 28.06% | 7.72M shares | |
| remainder | |||
27.52M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
147 holders · 16.05M shares · 24 new positions · 65 increased · 53 reduced · 38 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 2.29M | 8.31% | −487.9K | Aug 7, 2026 |
| Acadian Asset Management LLC | 1.02M | 3.70% | −216.0K | Aug 13, 2026 |
| Vanguard Capital Management LLC | 789.5K | 2.87% | −90.7K | Aug 13, 2026 |
| Jacobs Levy Equity Management, Inc | 782.1K | 2.84% | +425.8K | Aug 14, 2026 |
| JPMorgan Chase & Co | 756.6K | 2.75% | +296.2K | Aug 12, 2026 |
| Diametric Capital, LP | 697.8K | 2.54% | +336.7K | Aug 14, 2026 |
| Ameriprise Financial Inc | 670.1K | 2.44% | +106.7K | Aug 14, 2026 |
| Dimensional Fund Advisors LP | 625.4K | 2.27% | −46.3K | Aug 11, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Barclays PLC | 7.57% | 2.34M | 13G | May 13, 2025 |
| BlackRock, Inc. | 5.90% | 1.82M | 13G | Apr 3, 2025 |
| Ramya Rao | 5.42% | 1.66M | 13G | Feb 7, 2025 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 2, 2026 | Jian Xieofficer: President and COO | Sale | 2,127 | $19.66 | 359,924 |
| Sep 2, 2026 | Hanlin Gaoofficer: Chief Scientific Officer | Sale | 1,673 | $19.66 | 986,117 |
| Aug 27, 2026 | Hanlin Gaoofficer: Chief Scientific Officer | Sale | 939 | $19.91 | 987,790 |
| Aug 27, 2026 | Jian Xieofficer: President and COO | Sale | 1,193 | $19.91 | 362,051 |
| May 27, 2026 | Hanlin Gaoofficer: Chief Scientific Officer | Sale | 945 | $17.60 | 992,062 |
| May 27, 2026 | Jian Xieofficer: President and COO | Sale | 1,201 | $17.60 | 369,751 |
| Dec 2, 2025 | Hanlin Gaoofficer: Chief Scientific Officer | Sale | 1,075 | $28.33 | 952,890 |
| Dec 2, 2025 | Jian Xieofficer: President and COO | Sale | 1,140 | $28.33 | 336,749 |
| Nov 28, 2025 | Hanlin Gaoofficer: Chief Scientific Officer | Sale | 943 | $29.57 | 953,965 |
| Nov 28, 2025 | Jian Xieofficer: President and COO | Sale | 1,198 | $29.57 | 337,889 |
House and Senate disclosures
Not reported.